NYVAC vaccinia virus recombinants comprising heterologous insects
US Application 08/223,842
Filed on 1994-04-06
Filed on 1994-04-06
NYVAC vaccinia virus recombinants comprising heterologous insects
US Patent 5,494,807
Filed on 1993-08-12
Filed on 1993-08-12
NYVAC vaccinia virus recombinants comprising heterologous insects
US Application 07/897,382
Filed on 1992-06-11
Filed on 1992-06-11
NYVAC vaccinia virus recombinants comprising heterologous insects
US Application 07/847,951
Filed on 1992-03-06
Filed on 1992-03-06
NYVAC vaccinia virus recombinants comprising heterologous insects
US Application 07/715,921
Filed on 1991-06-14
Filed on 1991-06-14
NYVAC vaccinia virus recombinants comprising heterologous insects
US Application 07/713,967
Filed on 1991-06-11
Filed on 1991-06-11
A Variant Of Humanized Col-1 Antibody Rendered Less Immunogenic By Replacing, With Their Human Counterparts, Most Of The Murine Framework Residues That Were Presumed Crucial For Antigen Binding
Patent Cooperation Treaty
PCT/US2005/047431
Filed on 2005-12-30
PCT/US2005/047431
Filed on 2005-12-30
Acridone-Derived Compounds Useful as Antineoplastic and Antiretroviral Agents
Canada
2525550
Filed on 1997-04-09
2525550
Filed on 1997-04-09
METHODS AND COMPOSITIONS FOR USE IN SPLICEOSOME MEDIATED RNA TRANS-SPLICING
European Patent
02714709.9
Filed on 2002-01-08
02714709.9
Filed on 2002-01-08